{"id":"W2908332469","doi":"10.1016/j.jchf.2018.10.017","title":"Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease","year":2018,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Servier; Bayer Fund; Cytokinetics; Forest Laboratories; Novartis; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Takeda Pharmaceuticals U.S.A.; Boehringer Ingelheim; Amgen; Hartstichting; Gilead Sciences","keywords":"Spironolactone; Medicine; Discontinuation; Hyperkalemia; Renal function; Internal medicine; Heart failure; Kidney disease; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001049916,0.0002919003,0.00149644,0.0002509922,0.0002471883,0.0005649081,0.0002174177,0.0005308196,0.0008302772],"category_scores_gemma":[0.002598209,0.0001382427,0.0009004171,0.0002547071,0.0003138085,0.000660304,0.0002540186,0.0009889356,0.0001097616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004145937,"about_ca_system_score_gemma":0.0004999657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005839777,"about_ca_topic_score_gemma":0.0009680198,"domain_scores_codex":[0.9994735,0.0001997974,0.00007428645,0.00007263263,0.000102151,0.00007777992],"domain_scores_gemma":[0.9984565,0.0006431946,0.0003664171,0.00008781682,0.0001056691,0.0003404099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3672651,0.00401039,0.4503569,0.0009835346,0.003613515,0.0006715351,0.0003378369,0.001256885,0.009346259,0.0003067326,0.0009412497,0.16091],"study_design_scores_gemma":[0.02309426,0.05364347,0.9151514,0.0001795828,0.002034185,0.0006496109,0.000261367,0.001519645,0.001268807,0.0003284346,0.001819839,0.00004942368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910777,0.007356028,0.00009882393,0.000231434,0.00005480938,0.00002617735,0.000176343,0.000007679952,0.0009710653],"genre_scores_gemma":[0.9983747,0.0009136288,0.00008138212,0.0001687413,0.0001181367,0.00001489038,0.0002011875,0.000001403898,0.0001259733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00149644,"threshold_uncertainty_score":0.00555259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003551189435951597,"score_gpt":0.2200956619195293,"score_spread":0.2165444724835777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}